Mutations in Patients With Nonsevere Hemophilia and Inhibitors
| Location . | Mutation . | Factor VIII Level (%) . | Reference . | |||
|---|---|---|---|---|---|---|
| Domain . | Exon . | Codon . | Codon/Amino Acid . | VIII:C . | VIII:Ag . | . |
| A1 | 5 | 198 | CTT to CAT | 2 | 5 | |
| Leu to His | ||||||
| Pieneman et al19 | ||||||
| A2 | 12 | 593 | CGC to TGC | 9 | 13 | |
| Arg to Cys | ||||||
| A2 | 14 | 701 | GGC to AGC | 2 | — | Bidichandani et al20 |
| Gly to Asp | ||||||
| A3 | 14 | 1689 | CGC to CAC | 11 | 100 | Schwaab et al21 |
| Arg to His | ||||||
| C1 | 2 | 2150 | CGT to CAT | 12 | — | Santagostino et al22* |
| Arg to His | ||||||
| C2 | 24 | 2209 | CGA to CAA | 7 | 130 | Schwaab et al23* |
| Arg to Gln | ||||||
| C2 | 25 | 2229 | TGG to TGT | 3 | — | Naylor et al24 |
| Trp to Cys | ||||||
| Location . | Mutation . | Factor VIII Level (%) . | Reference . | |||
|---|---|---|---|---|---|---|
| Domain . | Exon . | Codon . | Codon/Amino Acid . | VIII:C . | VIII:Ag . | . |
| A1 | 5 | 198 | CTT to CAT | 2 | 5 | |
| Leu to His | ||||||
| Pieneman et al19 | ||||||
| A2 | 12 | 593 | CGC to TGC | 9 | 13 | |
| Arg to Cys | ||||||
| A2 | 14 | 701 | GGC to AGC | 2 | — | Bidichandani et al20 |
| Gly to Asp | ||||||
| A3 | 14 | 1689 | CGC to CAC | 11 | 100 | Schwaab et al21 |
| Arg to His | ||||||
| C1 | 2 | 2150 | CGT to CAT | 12 | — | Santagostino et al22* |
| Arg to His | ||||||
| C2 | 24 | 2209 | CGA to CAA | 7 | 130 | Schwaab et al23* |
| Arg to Gln | ||||||
| C2 | 25 | 2229 | TGG to TGT | 3 | — | Naylor et al24 |
| Trp to Cys | ||||||
Factor VIII abbreviations are as in Table 1.
Maximal inhibitor titer reported and >100 BU/mL.